Biomar Microbial Technologies has invested 2 million euros in the expansion of its León factory to produce kilograms of APIs for the pharmaceutical, cosmetics, food, agriculture and energy industries. The factory’s capacity for the production of active raw materials is now more than 3,000 liters.

Managing director Antonio Fernandez Medarde said, “We have the necessary infrastructure to become the lab for the development of production methods for new therapeutic entities. We have met GMP quality standards applying to international external labs and the large-scale production of pharmaceuticals, complying with international regulations in this area.”

Biomar prevents contamination by working with a single product line per campaign in the API processing and fermentation phases. Also, 20% of the investment went to the creation of a white room containing purified air in order to prevent the external pollution of the different substances.

According to the company, this expansion allows for a reduction of research production and development times for third party companies, allowing them to optimize scale-up processes, bolstering effectiveness with low performance compounds and reducing response times to customer orders. According to the company, 95% of its capacity will be employed to serve foreign multinationals, and 5% will be for companies on the domestic market.